1/53
Vocabulary practice flashcards covering cell signaling pathways, GPCR second messengers, cell cycle phases, cyclin-CDK regulation, chromosome cohesion, checkpoints, and stem cell biology.
Endocrine signaling
A form of extracellular signaling where signals are released into the bloodstream and travel long distances to reach distant target cells, often producing a slower but long-lasting effect.
Paracrine signaling
A type of extracellular signaling where signaling molecules act locally and rapidly on nearby cells.
Autocrine signaling
A form of extracellular signaling where a cell releases signals that target and bind to receptors on the cell itself.
Juxtacrine signaling
Direct intercellular communication mediated by plasma-membrane-attached proteins through physical contact between neighboring cells.
Dissociation constant (Kd)
A measure of binding affinity that shares an inverse relationship with affinity; the lower the Kd, the stronger the binding affinity.
GPCR activation mechanism
Following ligand binding to a GPCR, the β and γ subunits dissociate, causing the α subunit to release GDP and bind GTP; the activated α subunit binds the effector, while β/γ subunits bind together to open an ion channel.
Adenylyl cyclase
An effector enzyme activated by the GTP-bound α subunit of a GPCR that synthesizes the second messenger cAMP from ATP.
Cyclic AMP (cAMP)
A second messenger synthesized from ATP by adenylyl cyclase that activates protein kinase A (PKA) and is broken down into AMP by phosphodiesterase (PDE).
Phosphodiesterase (PDE)
An enzyme that catalyzes the hydrolysis of cAMP to AMP to terminate second messenger signaling; can be phosphorylated and activated by PKA as part of a negative feedback loop.
Guanylyl cyclase
An enzyme that synthesizes cyclic GMP (cGMP).
Cyclic GMP (cGMP)
A second messenger produced by guanylyl cyclase that opens cation channels in rod cells of the eye and activates protein kinase G (PKG).
Phospholipase C (PLC)
A G protein-activated enzyme that cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) to directly generate two second messengers: DAG and IP3.
Diacylglycerol (DAG)
A second messenger generated by phospholipase C (PLC) cleavage of PIP2 that activates protein kinase C (PKC).
Inositol trisphosphate (IP3)
A second messenger generated by phospholipase C (PLC) cleavage of PIP2 that opens and activates Ca2+ channels in the endoplasmic reticulum (ER).
Synthesis of DAG and IP3
A pathway where phosphatidylinositol (PI) is phosphorylated to PIP and then to PIP2; upon ligand binding to a surface receptor, activated phospholipase C (PLC) cleaves PIP2 into DAG and IP3.
Negative feedbacks suppressing GPCR/cAMP/PKA
Three regulatory mechanisms: inactivation of Gαs by hydrolyzing GTP to GDP, hydrolysis of cAMP to AMP by phosphodiesterase (PDE), and receptor desensitization (oversaturation) following prolonged exposure to epinephrine.
Human Epidermal Growth Factor Receptors (HER)
A family of four receptor tyrosine kinases (RTKs) in humans consisting of HER1, HER2, HER3, and HER4.
HER2
An epidermal growth factor receptor tyrosine kinase that cannot bind any ligand on its own and instead forms heterodimers with HER1, HER3, or HER4.
SH2 domain
A specialized protein domain that binds to phosphotyrosine residues on activated receptor tyrosine kinases (RTKs).
Ras cascade (RTK signal relay)
A downstream kinase signaling relay activated by RTKs following the sequential order: Ras → Raf → MEK → MAP kinase.
SHP1 and SOCS proteins
Negative regulators that terminate signal transduction from the erythropoietin receptor (EpoR); SHP1 provides short-term termination, whereas SOCS provides long-term termination.
Smad proteins
Target signaling proteins in the TGF-β pathway classified into three types: receptor-regulated Smads (R-smads), Co-smads, and inhibitory Smads (I-smads).
Proteasomal degradation signaling pathways
Developmental and physiological signaling cascades that utilize targeted degradation of components by the proteasome, including Wnt, Hedgehog, and NF-κB.
Canonical Wnt signaling pathway
A pathway acting as a molecular switch; activation by Wnt proteins prevents the destruction of β-catenin, allowing it to accumulate, enter the nucleus, and regulate specific gene transcription.
NF-κB signaling pathway
An immune-response pathway activated by inflammatory factors; when inactive, NF-κB is bound to I-κBα, and phosphorylation of I-κBα activates the pathway to induce gene transcription.
G0 phase
A quiescent interphase state where the cell is not actively dividing.
G1 phase
An interphase period dedicated to preparation for S phase during which centrioles begin duplication.
S phase
The cell cycle interphase stage of DNA synthesis where genomic DNA duplicates and centrioles continue duplicating.
G2 phase
An interphase stage where centrioles finish duplicating and the cell prepares for mitosis; incomplete DNA replication arrests the cell cycle at this phase.
M phase
The cell cycle phase during which nuclear division (mitosis) occurs.
CDK1
The cyclin-dependent kinase that regulates entry into and progression through mitosis (M phase).
CDK2
The cyclin-dependent kinase responsible for regulating the G1/S transition.
CDK4 and CDK6
The cyclin-dependent kinases that regulate the G1 phase of the cell cycle.
Cyclins
Regulatory protein subunits categorized into four classes (G1, G1/S, S, and mitotic M) that direct the specificity of kinase subunits and are present only during the cell cycle stages they trigger.
Mechanisms of CDK activity control
Three mechanisms ensuring CDKs are active only at the appropriate time and phase: cyclin binding, phosphorylation and dephosphorylation of the CDK subunit, and binding by cyclin-dependent kinase inhibitors (CKIs).
Whi5
A cell cycle transcriptional repressor protein.
Retinoblastoma (Rb) protein
A repressor protein that binds E2F transcription factors to inhibit G1/S progression; phosphorylation by kinases weakens its grip, releasing E2F to trigger a positive feedback wave of gene expression for irreversible S phase entry.
Cdh1
A cell cycle regulator active when dephosphorylated and inactive when phosphorylated; upon activation by Cdc14, it targets both S and mitotic cyclins for degradation.
Cdc14
A phosphatase in yeast that dephosphorylates and activates Cdh1 to trigger degradation of S and mitotic cyclins.
Sic1
A cyclin-dependent kinase inhibitor (CKI) phosphorylated by G1/S CDK and targeted for proteolysis; binds and inhibits kinase complexes to prevent premature DNA replication and inhibit S phase onset.
Shugoshin
A protein that recruits the phosphatase PP2A to the centromere during G2 to protect centromeric cohesion.
PP2A
A phosphatase recruited by Shugoshin to centromeric regions to protect cohesin complexes from premature removal.
PIK1 and Aurora B
Protein kinases that phosphorylate cohesins during M phase, leading to the removal of cohesin from chromosome arms.
Separase
An enzyme that cleaves residual cohesin complexes from the centromere during M phase to allow sister chromatid separation.
DNA damage response sensor kinases
Protein kinases including DNA-PK, ATM, and ATR that detect DNA damage and activate downstream signaling mediators (such as Chk1, Chk2, and MK2).
p53
A tumor suppressor and checkpoint regulator downstream of DNA damage signaling that can trigger apoptosis via caspases when damage cannot be repaired.
Self-renewal
The defining property of stem cells to undergo cell division to generate additional stem cells.
Pluripotency
The developmental capacity of a single stem cell to differentiate into all different cell types of the body.
Embryonic stem cells
Pluripotent stem cells derived from the inner cell mass of a blastocyst.
Induced pluripotent stem cells (iPSCs)
Adult somatic cells that have been genetically reprogrammed back into an embryonic-like, pluripotent state.
Adult stem cells
Undifferentiated, multipotent cells residing in developed tissues (such as bone marrow, adipose, skin, and brain) that maintain tissue turnover via self-renewal.
Stem cell niche
A specialized local microenvironment that protects and regulates stem cells, maintaining their self-renewal capacity without differentiation.
Intestinal stem cell niche
A microenvironment situated at the base of the intestinal crypt containing supportive Paneth cells.
Bone marrow stem cell niche
A microenvironment regulating hematopoietic stem cells (HSCs) that provides stem cell factor (SCF) for maintenance and uses CXCL12 to anchor HSCs within the niche.